Long-Term Health Related Quality of Life Following Uterine Fibroid Embolization in a Predominantly Black African Population: A Retrospective Cohort Study
Uterine Fibroid Embolization (UFE) is one of the effective options available for treatment of symptomatic uterine fibroids with documented improvement in the quality of life and reduction in symptoms. The study assessed long-term quality of life post-uterine fibroid embolization in a mostly black population, noting scanty local or African research on this topic despite evidence suggesting a higher fibroid burden among black women. This retrospective study examined patients who underwent UFE from 2009 to 2014. Participants completed online demographic and UFS-QOL surveys. Statistical tests included Wilcoxon signed rank tests for HRQOL score differences and Pearson correlation for associations between independent factors and outcomes like quality of life and symptom severity. Data from 77 participants showed a median follow-up of eight years post-UFE. Median health-related quality of life significantly improved from baseline, with a median score of 88.6 (62.9 - 98.3). Symptom severity score also decreased significantly from baseline (54.7 to 21.9, p < 0.001). Additionally, 31.1% reported follow-up fibroid treatments, 14.3% had major repeat procedures, and 22% reported pregnancies post-UFE, with 13% having children thereafter.
Cite this paper
Kioko, M. , Temmerman, M. , Obura, T. and Lusambili, A. (2024). Long-Term Health Related Quality of Life Following Uterine Fibroid Embolization in a Predominantly Black African Population: A Retrospective Cohort Study. Open Access Library Journal, 11, e1452. doi: http://dx.doi.org/10.4236/oalib.1111452.
Cardozo, E.R., Clark, A.D., Banks, N.K., Henne, M.B., Stegmann, B.J. and Segars, J.H. (2012) The Estimated Annual Cost of Uterine Leiomyomata in the United States. American Journal of Obstetrics & Gynecology, 206, 211.e1-211.e9. https://doi.org/10.1016/j.ajog.2011.12.002
Baird, D.D., Dunson, D.B., Hill, M.C., Cousins, D. and Schectman, J.M. (2003) High Cumulative Incidence of Uterine Leiomyoma in Black and White Women: Ultrasound Evidence. American Journal of Obstetrics & Gynecology, 188, 100-107. https://doi.org/10.1067/mob.2003.99
Ryan, G.L., Syrop, C.H. and Van Voorhis, B.J. (2005) Role, Epidemiology, and Natural History of Benign Uterine Mass Lesions. Clinical Obstetrics and Gynecology, 48, 312-324. https://doi.org/10.1097/01.grf.0000159538.27221.8c
Marshall, L.M., Spiegelman, D., Barbieri, R.L., Goldman, M.B., Manson, J.E., Colditz, G.A., et al. (1997) Variation in the Incidence of Uterine Leiomyoma among Premenopausal Women by Age and Race. Obstetrics & Gynecology, 90, 967-973. https://doi.org/10.1016/S0029-7844(97)00534-6
Marsh, E.E., Ekpo, G.E., Cardozo, E.R., Brocks, M., Dune, T. and Cohen, L.S. (2013) Racial Differences in Fibroid Prevalence and Ultrasound Findings in Asymptomatic Young Women (18-30 Years Old): A Pilot Study. Fertility and Sterility, 99, 1951-1957. https://doi.org/10.1016/j.fertnstert.2013.02.017
Templeman, C., Marshall, S.F., Clarke, C.A., Henderson, K.D., Largent, J., Neuhausen, S., et al. (2009) Risk Factors for Surgically Removed Fibroids in a Large Cohort of Teachers. Fertility and Sterility, 92, 1436-1446. https://doi.org/10.1016/j.fertnstert.2008.08.074
Huyck, K.L., Panhuysen, C.I., Cuenco, K.T., Zhang, J., Goldhammer, H., Jones, E.S., et al. (2008) The Impact of Race as a Risk Factor for Symptom Severity and Age at Diagnosis of Uterine Leiomyomata among Affected Sisters. American Journal of Obstetrics & Gynecology, 198, 168.e1-168.e9. https://doi.org/10.1016/j.ajog.2007.05.038
Kjerulff, K.H., Langenberg, P., Seidman, J.D., Stolley, P.D. and Guzinski, G.M. (1996) Uterine Leiomyomas. Racial Differences in Severity, Symptoms and Age at Diagnosis. Journal of Reproductive Medicine, 41, 483-490.
Moore, A.B., Flake, G.P., Swartz, C.D., Heartwell, G., Cousins, D., Haseman, J.K., et al. (2008) Association of Race, Age and Body Mass Index with Gross Pathology of Uterine Fibroids. Journal of Reproductive Medicine, 53, 90-96.
Borah, B.J., Nicholson, W.K., Bradley, L. and Stewart, E.A. (2013) The Impact of Uterine Leiomyomas: A National Survey of Affected Women. American Journal of Obstetrics & Gynecology, 209, 319.e1-319.e20. https://doi.org/10.1016/j.ajog.2013.07.017
Er, M. (2005) Prospective Data Collection of a New Procedure by a Specialty Society. Obstetrics & Gynecology, 106, 44-51. https://doi.org/10.1097/01.AOG.0000165827.66541.dd
Sankaran, S. and Manyonda, I.T. (2008) Medical Management of Fibroids. Best Practice & Research Clinical Obstetrics & Gynaecology, 22, 655-676. https://doi.org/10.1016/j.bpobgyn.2008.03.001
Goodwin, S.C., Vedantham, S., McLucas, B., Forno, A.E. and Perrella, R. (1997) Preliminary Experience with Uterine Artery Embolization for Uterine Fibroids. Journal of Vascular and Interventional Radiology, 8, 517-526. https://doi.org/10.1016/S1051-0443(97)70603-1
Hirst, A., Dutton, S., Wu, O., Briggs, A., Edwards, C., Waldenmaier, L., et al. (2008) A Multi-Centre Retrospective Cohort Study Comparing the Efficacy, Safety and Cost-Effectiveness of Hysterectomy and Uterine Artery Embolisation for the Treatment of Symptomatic Uterine Fibroids. The HOPEFUL Study. Health Technology Assessment, 12, 1-248. https://doi.org/10.3310/hta12050
Spies, J.B., Myers, E.R., Worthington-Kirsch, R., Mulgund, J., Goodwin, S., Mauro, M., et al. (2005) The FIBROID Registry: Symptom and Quality-of-Life Status 1 Year after Therapy. Obstetrics & Gynecology, 106, 1309-1318. https://doi.org/10.1097/01.AOG.0000188386.53878.49
Goodwin, S.C., Spies, J.B., Worthington-Kirsch, R., Peterson, E., Pron, G., Li, S., et al. (2008) Uterine Artery Embolization for Treatment of Leiomyomata: Long-Term Outcomes from the FIBROID Registry. Obstetrics & Gynecology, 111, 22-33. https://doi.org/10.1097/01.AOG.0000296526.71749.c9
Spies, J.B., Coyne, K., Guaou, N.G., Boyle, D., Skyrnarz-Murphy, K. and Gonzalves, S.M. (2002) The UFS-QOL, a New Disease-Specific Symptom and Health-Related Quality of Life Questionnaire for Leiomyomata. Obstetrics & Gynecology, 99, 290-300. https://doi.org/10.1097/00006250-200202000-00021
Mariara, C., Obura, T., Hacking, N. and Stones, W. (2017) One Year Symptom Severity and Health-Related Quality of Life Changes among Black African Patients Undergoing Uterine Fibroid Embolisation. BMC Research Notes, 10, Article No. 240. https://doi.org/10.1186/s13104-017-2558-0
Hacking, N. (2014) Costing Issues and UAE in the Developing World. In: Reidy, J., Hacking, N. and McLucas, B., Eds., Radiological Interventions in Obstetrics and Gynaecology, Springer, Berlin, 149-154. https://doi.org/10.1007/174_2014_1011
Sandberg, E.M., Tummers, F.H., Cohen, S.L., Van Den Haak, L., Dekkers, O.M. and Jansen, F.W. (2018) Reintervention Risk and Quality of Life Outcomes after Uterine-Sparing Interventions for Fibroids: A Systematic Review and Meta-Analysis. Fertility and Sterility, 109, 698-707.e1. https://doi.org/10.1016/j.fertnstert.2017.11.033
van der Kooij, S.M., Hehenkamp, W.J., Volkers, N.A., Birnie, E., Ankum, W.M. and Reekers, J.A. (2010) Uterine Artery Embolization vs Hysterectomy in the Treatment of Symptomatic Uterine Fibroids: 5-Year Outcome from the Randomized EMMY Trial. American Journal of Obstetrics & Gynecology, 203, 105.e1-105.e13. https://doi.org/10.1016/j.ajog.2010.01.049
de Bruijn, A.M., Ankum, W.M., Reekers, J.A., Birnie, E., van der Kooij, S.M., Volkers, N.A., et al. (2016) Uterine Artery Embolization vs Hysterectomy in the Treatment of Symptomatic Uterine Fibroids: 10-Year Outcomes from the Randomized EMMY Trial. American Journal of Obstetrics & Gynecology, 215, 745.e1-745.e12. https://doi.org/10.1016/j.ajog.2016.06.051
